MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2023 International Congress

    Anodal transcranial direct current stimulation could change the metabolomic profiles of cerebrospinal fluid in Parkinson’s disease

    W. Jang, H-T. Kim (Gangneung, Republic of Korea)

    Objective: We tried to identify meaningful metabolite change after anodal tDCS in clinically diagnosed PD patients by adopting metabolomic analysis Background: Transcranial direct current stimulation…
  • 2023 International Congress

    A network imaging biomarker of X-linked dystonia-parkinsonism

    M. Niethammer, C. Tang, R. Jamora, A. Vo, N. Nguyen, Y. Ma, S. Peng, J. Waugh, D. Eidelberg (Manhasset, USA)

    Objective: To characterize a metabolic brain network associated with X-linked dystonia-parkinsonism (XDP). Background: X-linked dystonia-parkinsonism (XDP, DYT/PARK-TAF1, Lubag) is an X-linked recessive movement disorder characterized…
  • 2023 International Congress

    Correlation between levels of plasma neurofilament light chain and freezing of gait in Parkinson’s disease

    Y. Zhu, X. Yang, H. Ren, A. Pang (Kunming, China)

    Objective: This study evaluated the correlation between neurofilament light chain (NfL) and freezing of gait (FOG) in Parkinson's disease (PD). Background: PD patients frequently experience…
  • 2023 International Congress

    Clinical and functional determinants of motor reserve in patients with de novo Parkinson’s disease

    S. Prange, M. Hoenig, H. Theis, E. Metereau, S. Thobois, T. van Eimeren (Cologne, Germany)

    Objective: To determine the clinical determinants and the role of serotonergic innervation on motor reserve in patients with de novo Parkinson's disease. Background: Patients with…
  • 2023 International Congress

    Timed-up-and-go tests under dual-task conditions: Influence of different tasks on gait parameters in Parkinsonian patients

    C. Dupeyrat (HOMBURG, Germany)

    Objective: To analyse the effect of dual tasking on the Parkinson gait. Background: Parkinson's disease has a strong impact on gait and posture, leading to…
  • 2023 International Congress

    Clinical usefulness of tandem gait test for estimating gait and balance in de novo Parkinson’s disease

    JS. Park, HT. Kim, SH. Lim (Busan, Republic of Korea)

    Objective: The purpose of this study is to objectively evaluate the gait and balance in patients with Parkinson’s disease showing abnormal tandem gait, using three-dimensional motion analysis.…
  • 2023 International Congress

    Spiral Tunneling Technique for passing electrode lead for Deep Brain Stimulation(DBS) surgery in Parkinson’s disease(PD)

    A. Uppar, D. Srinivas (BANGALORE, India)

    Objective: To compare the conventional “Twist & Anti-Twist” technique and “Spiral Tunnelling Technique”(STT) for tunnelling the leads for Deep Brain Stimulation surgery in PD. Background:…
  • 2023 International Congress

    Acute-onset parkinsonism secondary to bilateral extrapontine myelinolysis of the basal ganglia: case report

    N. Sarhan (Zagazig, Egypt)

    Objective: Although rapid osmolar correction, mainly in the setting of hyponatremia is the main risk factor of osmotic demyelination syndrome, the pathogenesis of the syndrome…
  • 2023 International Congress

    Genetic outcomes of South Asian Parkinsonism cohort: from a tertiary care hospital

    P. Paramanandam, A. S, A. Deenadayalu, I. N, K. Gowrishankar, T. Koshy (Chennai, India)

    Objective: To identify the genetic heterogeneity in 16 south Asian patient with Parkinson’s disease. Background: Parkinson’s disease(PD) is the second most progressive neurodegenerative disorder with…
  • 2023 International Congress

    Effect of the 5-HT2A/2C inverse agonist nelotanserin on dyskinesia in the MPTP-lesioned marmoset

    C. Kwan, I. Frouni, D. Bédard, S. Nuara, J. Gourdon, P. Huot (Montreal, Canada)

    Objective: To determine the effect of the serotonin 2A/2C (5-HT2A/2C) receptor inverse agonist nelotanserin on dyskinesia in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-lesioned marmoset. Background: Nelotanserin is a…
  • « Previous Page
  • 1
  • …
  • 41
  • 42
  • 43
  • 44
  • 45
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley